Prestium Pharma is the branded subsidiary of Renaissance Pharma, Inc. We are committed to improving patients’ lives by reliably supplying high-quality, complex pharmaceutical products.
We have an established and reliable, vertically-integrated manufacturing network. With mature, niche brands and a proven supply chain, all aspects of our business have a long track record of success.
PRESTIUM PHARMA, INC. ANNOUNCES PLANS FOR RELEASE OF IMPROVED OLUX® (CLOBETASOL PROPIONATE) FOAM
NEWTOWN, PA, March 19, 2015 - Prestium Pharma, Inc. announced it is planning to launch an improved version of OLUX® (clobetasol propionate), 0.05% Foam. The new product is designed to improve overall performance and patient compliance and includes modifications allowing for greater product uniformity, the ability to apply the foam directly to the affected area, and a valve assembly that does not require inversion for application. Earlier this year, a patent application was filed relating to the new product. Click here to read the full release http://www.prestiumpharma.com/press/.